Form 8-K - Current report:
SEC Accession No. 0000950170-25-033653
Filing Date
2025-03-05
Accepted
2025-03-05 16:25:47
Documents
12
Period of Report
2025-03-03
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-20250303.htm   iXBRL 8-K 53211
2 EX-16.1 xene-ex16_1.htm EX-16.1 4138
  Complete submission text file 0000950170-25-033653.txt   180484

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xene-20250303.xsd EX-101.SCH 30841
14 EXTRACTED XBRL INSTANCE DOCUMENT xene-20250303_htm.xml XML 4684
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 25711529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)